Minoxidil Market Statistisc | Analysis Report 2023-2032

A new Global Market Insights Inc. study estimates that the global Minoxidil Market size  is likely to grow past USD 2.5 billion by 2032. Increasing consumer spending on haircare products, rising cases of alopecia, growing disease burden of hypertension, and surging product availability through online distribution channels is likely to outline industry revenues.

Increasing consumer awareness around personal health and hygiene are likely to fuel the minoxidil market through 2032. With fast-paced modern lifestyles bringing their fair share of stress factors to the world’s population, health concerns such as hypertension, heart disease, insomnia, and hyperglycemia are becoming far too common.

Meanwhile, growing ill effects of air and water pollution are fueling other growth drivers for the minoxidil by giving rise to the issue of hair loss. In today’s personal grooming-focused world, the issue of hair loss can easily lead to psychological problems for people, including anxiety, social withdrawal, and depression, which in turn lead to the aforementioned health concerns.

Some of the fields available in report -

Below is a brief outline of the three key trends that are fostering global demand for minoxidil market:

1. Rising instances of hair loss caused by air pollution:

Recent studies checking the overall health impact of dust and fuel particles on human scalp have found that air pollution can, among other health concerns, cause hair loss from longer exposure. Researchers discovered that when exposed to some of the most common air pollutants human hair sees a decrease in four key hair protein levels, including CDK2, beta-catenin, cyclin E, and cyclin D1. These proteins are directly responsible for the retention as well as growth of hair among humans.

The study further found that the effect of air pollution on hair health increased when the volume of the airborne particles increased – effectively suggesting that people living in urban areas or in proximity to industrial areas have a higher risk of going bald.

Minoxidil addresses the effects of onset hair loss by reversing the miniaturisation of hair follicles, increasing blood flow to the scalp, and stimulating follicle movement to the growth phase.

**Request for a free sample of this research report @ https://www.gminsights.com/request-sample/detail/750** 

2. Growing cases of alopecia across the globe:

According to the National Alopecia Areata Foundation, approximately 2% of the world’s population will develop alopecia areata at one point in their lifetime. What does that mean? That means that nearly 160 million people worldwide have had, will have, or have alopecia areata. The foundation estimates that over 6.7 million people in the US will get alopecia at some point and currently about 700,000 people across the US are living with the condition.

While alopecia areata can start in patients at any age, most people develop the disease during the early stages of their life. In fact, more than 80% of individuals show signs of the ailment before hitting the age of 40, while 40% start showing symptoms by the age of 20. Topical application of minoxidil solution is one of the only solutions to induce hair regrowth in patients with alopecia.

3. Increasing disease burden of hypertension worldwide:

Hypertension is regarded as one of the leading causes of death worldwide, being responsible for more than 12.8% of deaths annually, which translates to 7.5 million lives. Over the past three decades, the overall number of people aged 30 years - 79 years with hypertension has effectively doubled to reach 1.28 billion worldwide. A recent WHO study found that that over half of the patients suffering from hypertension, 62% of men and 53% of women, or a total 720 million people, lack access to the treatment they need.

Among patients with resistant hypertension where multidrug regimen-based therapy has failed, minoxidil has shown to be capable of lowering blood pressure.

Overall, with three leading factors leading to the expansion of the patient pool, the demand for minoxidil is likely to increase notably by 2032.

**Browse our report store – GMIPulse - https://www.gminsights.com/gmipulse** 

About Global Market Insights Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

**Contact Us: **

Aashit Tiwari

Corporate Sales, USA

Global Market Insights Inc.

Toll Free: +1-888-689-0688

USA: +1-302-846-7766

Europe: +44-742-759-8484

APAC: +65-3129-7718

Email: mailto:sales@gminsights.com